Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
9 studies found for:    "methodist hospital" | Open Studies | "Heart Failure" | United States, Texas | Houston
Show Display Options
Rank Status Study
1 Recruiting AdaptResponse Clinical Trial
Condition: Heart Failure With Left Bundle Branch Block
Interventions: Device: aCRT ON;   Device: aCRT OFF
2 Recruiting A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Conditions: Heart Failure;   Coronary Artery Disease
Interventions: Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
3 Recruiting Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial)
Conditions: Mitral Regurgitation;   Mitral Valve Regurgitation
Intervention: Device: MitraClip System
4 Recruiting International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
Condition: Heart Failure
Interventions: Drug: Iobenguane I -123 Injection;   Device: Implantable Cardioverter Defibrillator;   Drug: Thyroid blocking
5 Recruiting MOMENTUM 3 Continued Access Protocol
Condition: Advanced Refractory Left Ventricular Heart Failure
Intervention: Device: HeartMate 3 LVAS
6 Recruiting EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Condition: Heart Failure
Interventions: Drug: Empagliflozin;   Drug: Placebo
7 Recruiting EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Condition: Heart Failure
Interventions: Drug: Empagliflozin;   Drug: Placebo
8 Recruiting Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
Conditions: Heart Failure;   Cardiac Failure;   Congestive Heart Failure;   Heart Failure, Left-sided
Interventions: Device: HeartAssist 5® VAD System;   Device: Control VAD
9 Recruiting A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
Conditions: Heart Failure;   Respiratory Insufficiency;   Stroke Acute;   Infectious Diseases;   Rheumatic Diseases
Interventions: Drug: Rivaroxaban, 10 mg;   Drug: Rivaroxaban, 7.5 mg;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.